Study on pharmacokinetics and bioequivalence of itraconazole dispersible tablets in healthy volunteers

何周康,阳利龙,祝文兵,张毕奎,朱运贵,徐萍
DOI: https://doi.org/10.3969/j.issn.1672-108X.2007.03.005
2007-01-01
Abstract:Objective:To study the pharmacokinetics and bioequivalence between itraconazole dispersible tablets and itraconazole capsules in 18 male healthy volunteers.Method:A dose of 0.2 g itraconazole dispersible tablets and itraconazule capsules were given according to a randomized cross-over design.Plasma concentrations of itraconazole were determined by HPLC.ANOVA was used to check the difference of the means of the pharmacokinetic parameters between the two preparations.Bioequivalence was determined by t-tests.Results:The concentration-time curves of both preparations fitted to a one-compartment model.The main pharmacokinetic parameters of itraconazole dispersible tablets and itraconazolc cap- sules AUC_(0→72),AUC_(0→(?)),C_(max),T_(max),t_(1/2)were(2221.9±762.9)and(2311.9±844.4)ng·h~(-1)·mL~(-1),(2374.2±790.8)and(2473.3±878.9)ng·h~(-1)·mL~(-1),(179.8±56.8)and(174.1±64.1)ng/mL,(3.6±1.0)and(4.1±1.3)h,(16.5±4.2)and(17.5±3.1)h respec- tively.The relative bioavailability was(97.8±14.0)%.Conclusions:Itraconazole dispersible tablets and itraconazole capsules were bioequiva- lent.
What problem does this paper attempt to address?